121,134 GIP, another insulin secretion agonist, helps release insulin, particularly after eating, enhancing the effects of GLP-1 and thereby improving the overall therapeutic efficacy of the drug
A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered
In terms of opioid addiction, several GLP-1RAs have been shown to reduce self-administration and reinstatement of drug-seeking behavior for heroin, fentanyl, and oxycodone in rodent models [73-76]
High-protein snack ideas for post-surgery recovery include: Plain Greek yogurt with a few berries